OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr Sartor on Ongoing Prostate Cancer Research

March 13th 2024

Oliver Sartor, MD, discusses ongoing prostate cancer research, highlighting the importance of considering patient quality of life.

Dr Calais on Controversies in the Treatment of Patients With Prostate Cancer

March 13th 2024

Jeremie Calais, MD, PhD, discusses controversies and unresolved questions in the treatment of patients with prostate cancer.

Dr McCann on Navigating Work-Life Balance As a Woman in Oncology

March 12th 2024

Kelly E. McCann, MD, PhD, discusses her experiences with mentorship and work-life balance as a woman in oncology.

Dr Zhang on Topics of Ongoing Debate Within Prostate Cancer

March 12th 2024

Tian Zhang, MD, MHS, discusses areas of ongoing debate regarding prostate cancer management.

Dr Levy on the Potential for ADCs in NSCLC

March 12th 2024

Benjamin Levy, MD, explores the potential role of antibody-drug conjugates in non–small cell lung cancer.

Dr Richter on Proactive Toxicity Management With Bispecific Antibodies in Myeloma

March 12th 2024

Joshua Richter, MD, discusses the role of bispecific antibody therapy in myeloma and expands on toxicity management for these agents.

Dr Agarwal on QOL Considerations for Patients With Prostate Cancer

March 11th 2024

Neeraj Agarwal, FASCO, MD, discusses quality of life considerations for patients with prostate cancer.

Dr Graff on the Trajectory of Her Career in Breast Cancer

March 11th 2024

Stephanie L. Graff, MD, discusses the trajectory of her career growth in breast oncology and explains how different factors can play a role in an oncologist’s career path.

Dr Rugo on Challenges Faced as a Woman in Oncology

March 11th 2024

Hope S. Rugo, MD, discusses challenges that women face in the workplace in oncology care.

Dr Tripathy on the Management of Early-Stage HER2+ Breast Cancer

March 10th 2024

Debu Tripathy, MD, discusses current considerations for the management of early-stage HER2-positive breast cancer.

Dr Rugo on the Evolution of ADCs in HR+/HER2+ and HER2-Low Breast Cancer

March 9th 2024

Hope Rugo, MD, discusses the evolution of antibody-drug conjugates in hormone receptor–positive, HER2-positive, and HER2-low breast cancer.

Dr Park on the FDA Vote Supporting Lumisight Use for Breast Cancer Detection During Surgery

March 9th 2024

Ko Un “Clara” Park, MD, discusses the FDA's vote in support of Lumisight for patients with breast cancer undergoing breast conserving surgery.

Dr Huppert on Data Informing the Sequence of Systemic Therapy in Early-Stage TNBC

March 9th 2024

Laura A. Huppert, MD, discusses data informing the sequence of immunotherapy and chemotherapy regimens in early-stage triple-negative breast cancer.

Dr Smith on the Value of Mentorship in Oncology

March 8th 2024

Sonali M. Smith, MD, discusses the value of mentorship in oncology practice on International Women’s Day.

Dr Möller on Gender Biases in Oncology

March 8th 2024

Mecker G. Möller, MD, discusses the importance of addressing gender biases in oncology.

Dr Miller on the Importance of Patient Advocacy in Gynecologic Oncology

March 8th 2024

Eirwen M. Miller, MD, discusses the importance of advocating for women in gynecologic oncology on International Women’s Day.

Dr Litton on Navigating the Sequencing of PARP Inhibitors in Early-Stage TNBC

March 8th 2024

Jennifer K. Litton, MD, discusses challenges determining the optimal sequencing of PARP inhibitors in early-stage triple-negative breast cancer.

Dr Kalinsky on Unanswered Questions Regarding Genomic Testing in HR+ Breast Cancer

March 8th 2024

Kevin Kalinsky, MD, MS, discusses questions regarding the utility and implementation of genomic testing approaches in hormone receptor–positive breast cancer.

Dr Coopey on Institutional and Societal Initiatives to Support Women in Oncology

March 8th 2024

Suzanne B. Coopey, MD, FACS, discusses ways that women in oncology can feel further supported and advocated for in the cancer care space.

Dr Coopey on Addressing Gender Disparities in Cancer Care

March 8th 2024

Suzanne B. Coopey, MD, FACS, discusses the importance of addressing gender disparities in cancer care.